Pillar Biosciences, LC-SCRUM-Asia and LSI Medience collaborate for liquid biopsy screening in lung cancer

Vascarta commences NIH phase I clinical study of VAS-101 in sickle cell disease

Azra AI and 4DMedical partner on lung health intelligence

AstraZeneca reports positive Phase III results for Tagrisso and Orpathys

HUTCHMED reports positive Phase III results for ORPATHYS and TAGRISSO combination

ArkBio's Ziresovir gains US FDA Phase II clinical trial approval

Pharming launches Joenja in Japan for APDS patients aged four and above

Galvanize Therapeutics' new Aliya EX System completes first commercial procedures

Innovent doses first colorectal cancer patient with IBI363/TAK-928 in combination with bevacizumab

Obsidian Therapeutics advances Agni-01 study with first patient enrolled in registration-enabling cohort

Summit Therapeutics expands ivonescimab programme into bladder cancer with Phase II/III trial

Lilly secures FDA Breakthrough Therapy designation for olomorasib in pancreatic cancer

Genprex collaborates with Roche Diagnostics on NSCLC biomarker validation

Zai Lab's zoci receives FDA orphan designation for neuroendocrine carcinomas

Qatar approves Zepzelca combination as first-line maintenance therapy for extensive-stage small cell lung cancer